Practices

Cases Investigated

Beasley Allen is currently investigating cases involving prescription drugs. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Beasley Allen representing Houston County against opioid companies

December 14, 2017 - In the second lawsuit filed in two days on behalf of a local government, Beasley Allen is representing Houston County against opioid manufacturers blamed for creating a public health crisis. Read More


Beasley Allen files lawsuit related to opioid epidemic for City of Greenville

December 13, 2017 - Lawyers from Beasley Allen are representing the City of Greenville against opioid manufacturers whose marketing efforts have contributed to the opioid epidemic and created a public health... Read More


Doctors abandoning Invokana over increased risk of amputations

September 27, 2017 - The latest reported adverse side effect connected to Invokana – an increased risk of amputation – has led some doctors to stop prescribing the diabetes drug. Read More


New, contradictory evidence from Xarelto makers could lead to retrial for plaintiff

September 21, 2017 - There is an effective lab test to protect patients taking Xarelto, but that isn’t what jurors heard during last month’s trial against Johnson & Johnson’s Janssen Pharmaceuticals and... Read More


New trial for testosterone litigation starts next week

September 13, 2017 - Plaintiffs maintain that despite not being designed to treat symptoms of age-related testosterone decline, manufacturers marketed the products as “fountain of youth” drugs to lure men... Read More


Concern over Invokana adverse side effects continues to grow

August 25, 2017 - Reports of amputations connected to canagliflozin, the key ingredient in brand name medications Invokana and Invokamet, continue to underscore the drug’s dangers. Read More


Proton Pump Inhibitor (PPI) MDL granted

August 4, 2017 - Plaintiffs are suing PPI manufacturers after developing kidney damage linked to the use of PPIs. Studies dating back to the 1990s have linked PPIs, including Nexium, Prevacid, and Prilosec,... Read More


Johnson & Johnson, Janssen Pharmaceuticals legal battles over Risperdal continue

March 15, 2017 - Plaintiffs contend Janssen concealed the risk of Risperdal’s most devastating side effect, gynecomastia, or the abnormal growth of breast tissue in young boys. Read More


Bristol-Myers Squibb top-selling antipsychotic Abilify linked to users’ compulsive gambling

March 8, 2017 - When the FDA reviewed Abilify’s adverse events reports, 184 of them linked the drug with the impulse-control problems that developed in adults and children taking Abilify. The most... Read More


Lawsuits increase as research linking Proton Pump Inhibitor (PPI) heartburn drugs and kidney damage mounts

March 1, 2017 - A 1992 study first linked PPI use to Acute Interstitial Nephritis (AIN), inflammation in the spaces between the kidney tubules. Later studies linked PPI use with an increased risk of Acute... Read More


back to top